Patient P-03454

Synthetic patientONX-7 · Day 145 · 45–54 · F · baseline S06Steering view · 3D Open companion preview

Therapy response

Unstable

Tolerance

Improving

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S06
Day 31 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 31.

Primary contributors, last 14 days

Nutritional resilience+15
Toxicity-11
Inflammatory activity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

6.5/10

stable · +0.1 vs previous 14 d

Stress level

Daily log

2.8/10

improving · -0.3 vs previous 14 d

Pessimism score

Daily log

4.2/10

improving · -0.2 vs previous 14 d

Sleep quality

Wearable

58.5/100

improving · +2.4 vs previous 14 d

Libido

Daily log

5.3/10

stable · +0.2 vs previous 14 d

HRV

Wearable

60 ms

stable · -0.0 vs previous 14 d

Toxicity

Blood

8.3/100

improving · -3.5 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading drifting · 71 from the failing basin, 44 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +8.2
Butyrate producers intact
hidden · steering +7.5
Protein
supporter · GI -4 next day

Main detractors to watch

Antibiotic course
perturbation · steering -4.7
Poor-sleep week
perturbation · steering -3
Low-HRV stretch
perturbation · steering -2.7
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4supporter · 95%
Caffeine
-1.8no signal · 43%
Lactose
-1.5no signal · 37%
Alcohol
-0.8no signal · 20%
Histamine load
+0.7no signal · 16%
Dietary fat load
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.1 · butyrate capacity 71/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 57 ms
Sleep: 7.4 h
Steps: 7,675
Resting HR: 59 bpm

Daily log: GI score 16, nutritional resilience 73, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03104	48%	S14	AD-05	no change	27
P-03034	43%	S14	AD-05	no change	30
P-03369	43%	S18	AD-05	no change	37
P-03158	40%	S17	AD-05	no change	37
P-03122	38%	S13	AD-05	no change	40
P-03380	38%	S16	AD-05	improved	34
P-03424	36%	S12	AD-05	improved	41
P-03129	35%	S18	AD-05	no change	32
P-03111	34%	S07	AD-05	no change	48
P-03204	34%	S16	AD-05	improved	48
P-03441	32%	S19	AD-05	improved	37
P-03351	30%	S07	AD-05	no change	51